Skip to the page

Data / Drug companies / Lidocaine and menthol

Lidocaine and menthol: 17 companies and 36 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Lidocaine and menthol is listed in the FDA National Drug Code Directory by 17 companies, with 36 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are patch; gel; kit, and the newest product started marketing on November 2, 2026.

The request: Get every company that lists lidocaine and menthol in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
17
Products
36
Generic (ANDA) products
0 (0.0%)
Application numbers
2
Routes
Topical, Transdermal
Brand names
Pain Relief Gel-Patch, Pain Relief Gel-Patch, Heel Pain Relief Roll-On, LidoPro, Lidothol, Pain Relief Gel-Roll On, Albertson Lidocaine, Menthol Pain Relief Medicated Patch, LidoReal Patch
openFDA record search
api.fda.gov

Companies that list lidocaine and menthol

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Guangzhou Liuquanmiao Import & Export Trade Co., Ltd.9patch; gelOver the counter monograph drugsAugust 21, 2026
Shanghai Chuangshi Medical Technology (Group) Co., Ltd.6patch; gelOver the counter monograph drugsAugust 3, 2026
Veridian Healthcare4patchOver the counter monograph drugsJune 1, 2025
Advanced Rx of Tennessee, LLC3patchOver the counter monograph drugsJune 12, 2026
Florrax Pharmaceutical2kitOther unapproved drugsJuly 1, 2025
Ari Brands, LLC1patchOther unapproved drugsSeptember 1, 2023
Bullet Point LLC1gelOver the counter monograph drugsNovember 3, 2025
Chattem, Inc.1patchOver the counter monograph drugsFebruary 18, 2018
Clinic Pharma1patchOver the counter monograph drugsMarch 11, 2026
Fabrication Enterprises1patchOver the counter monograph drugsJuly 21, 2025
Forreal Pharmaceuticals LLC1patchOver the counter monograph drugsMay 15, 2024
Guangzhou Sumi Technology Innovation Co., Ltd1patchOver the counter monograph drugsMarch 30, 2026
InterMed Laboratories Private Limited1patchOther unapproved drugsNovember 22, 2019
Marcella Health1patchOver the counter monograph drugsOctober 24, 2025
Safeway1patchOver the counter monograph drugsApril 1, 2022
Shenzhen Yuwen E-Commerce Co., LTD.1patchOver the counter monograph drugsMarch 11, 2025
Yyba Corp1patchOver the counter monograph drugsNovember 2, 2026

Dosage forms

Dosage formProductsShare
Patch2877.8%
Gel616.7%
Kit25.6%

Marketing categories

Marketing categoryProductsShare
Over the counter monograph drugs3186.1%
Other unapproved drugs513.9%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.